Pharma News

A new study published in the Journal of Natural Products of the American Chemical Society and American Society of Pharmacognosy has shown that isolated cannabinoids or those in hemp extracts have t...

Tempol is being analysed in a double-blind, randomised, adaptive, Phase II/II clinical trial for Covid-19 treatment.

The FDA approved many new drugs and technologies over the past year, and in the dermatology world those approvals included treatments for a multitude of conditions. ...

Alembic Pharmaceuticals has gotten tentative approval for its abbreviated new drug application (ANDA) for dronedarone, a generic equivalent to Sanofi-Aventis’ anti-arrhythmic Multaq, which the FD...

In a medical first, doctors transplanted a pig heart into a patient in a last-ditch effort to save his life and a Maryland hospital said Monday that he’s doing well three days after the highly e...

Using two different free protein-predicting AI algorithms, computer scientists were almost able to model Omicron before the coronavirus variant had been physically mapped. ...

The future of Aduhelm, Biogen Inc's (BIIB.O) controversial and expensive Alzheimer's drug, may hinge on a decision due this week from the U.S. Medicare program on whether it will pay for the treatm...

Amgen’s Lumykras (sotorasib) — branded as Lumakras in the U.S. — has won conditional marketing approval in Europe for treating adults with KRAS G12C-mutated nonsmall-cell lung cancer (NSCLC) ...

France's health ministry will announce later on Tuesday a record of more than 350,000 new COVID infections over a 24-hour period, Health Minister Olivier Veran told lawmakers. ...

COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles (CNPs) to treat immune disorders, today announced the U.S. Food and Drug Administration (FDA) granted F...

Swiss drugmaker Idorsia (IDIA.S) said on Monday it has received the U.S. Food and Drug Administration's approval for its treatment for insomnia in adult patients. ...

A mystery brain illness that is baffling Canadian doctors is increasingly affecting young people, a doctor has claimed.